MinuteClinic highlights access and outcomes in clinically supervised weight-loss program

In-person and virtual services support chronic disease prevention and long-term metabolic health WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic®, the medical clinic inside select CVS Pharmacy® (NYSE: CVS) locations, is highlighting its clinically supervised weight-loss program to support earlier intervention and more accessible preventive care.

PRNewsWire • 6 hours ago

CVS Health (CVS) is a Top-Ranked Growth Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 12, 2026

Here's Why CVS Health (CVS) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 11, 2026

CVS Health: Still Cheap And Signs Of Improvement

CVS Health Corporation remains deeply undervalued despite persistent headwinds and an 11-year correction, with intrinsic value estimates well above current prices. Q1 2026 results showed 6.2% revenue growth and a 63.1% EPS increase, prompting management to raise full-year guidance for revenue, cash flow, and earnings. Margins and the medical benefit ratio are showing early signs of recovery, supporting management's and analysts' renewed optimism for double-digit EPS growth.

Seeking Alpha • May 11, 2026

Health Insurers Performing Better But There's Potential Trouble Ahead

Health insurance companies including UnitedHealthcare, CVS Health's Aetna, Centene and Blue Cross and Blue Shield plans owned by Elevance Health are seeing lower costs from patients submitting claims.

Forbes • May 10, 2026

CVS Health Q1 Earnings Call Highlights

CVS Health NYSE: CVS raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations.

MarketBeat • May 10, 2026

CVS Health: Rapidly Improving Metrics And Promising Recovery Deserve Reiterated Buy Rating

The +2.48% YoY payment hike for 2027 Medicare Advantage plans and Aetna's higher star rating support CVS Health's recovery prospects toward 2028 target margins. This is significantly aided by the prior premium re-pricing and the ongoing operational efficiencies, as observed in their FQ1 '26 MBR of 84.6% nearing 2019 levels. Readers must not forget their vertically integrated PBM and pharmacy capabilities, allowing them to drive lower medical costs and improved operational efficiencies.

Seeking Alpha • May 8, 2026

These Analysts Increase Their Forecasts On CVS Health After Strong Q1 Results

CVS Health Corp. (NYSE:CVS) on Wednesday posted upbeat first-quarter earnings and issued strong 2026 guidance.

Benzinga • May 7, 2026

CVS Health Q1 Earnings: We're (Finally) Back In Buy Territory

CVS Health Corporation delivered a strong Q1, with revenues of $100.4bn and adjusted EPS up ~14% to $2.57, surpassing expectations. CVS raised 2026 guidance: revenue to $405bn, adjusted EPS to $7.4, and cash flow from operations to $9.5bn, reflecting renewed operational momentum. Improvement in the medical benefit ratio to 84.6% and robust health insurance segment profitability signal a turnaround in CVS's core business.

Seeking Alpha • May 7, 2026

CVS's Aetna division is the latest insurer to report improving margins and cost controls, a positive sign for the industry

CVS attributed much of the improvement to a turnaround at its insurance unit, Aetna.

WSJ • May 6, 2026